相关实验视频
Updated: Jan 8, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
875
男人激素重置:GLP-1RAs,生活方式和丸激素如何改变与肥胖有关的问题
Kristina Groti Antonič1,2, Michael Zitzmann3
1Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.
概括
肥胖男性的功能性阴性双胞胎缺陷是未被认可的. 将丸激素治疗与抗肥胖药物的结合提供了一种新的护理标准,改善整体健康和生活质量.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 男人的健康 男人的健康
背景情况:
- 功能性性性双胞胎症,以丸激素缺乏为特征,显著影响过重和肥胖男性的生活质量.
- 尽管它具有深远的影响,但在临床实践中经常被忽视.
研究的目的:
- 提供关于将丸激素治疗与现代抗肥胖药物治疗相结合的最新信息.
- 为了将这种组合作为一种潜在的新标准,为肥胖男性与功能性阴性腺失调的护理.
主要方法:
- 针对丸激素治疗和抗肥胖药物治疗的当前文献的集中审查.
- 对包括代谢,血管,性,认知和骨健康在内的好处的分析.
主要成果:
- 生活方式的修改是第一线的,药物和手术选择补充它们.
- 腹腔外科手术和GLP-1受体激动剂 (GLP-1RAs) 促进体重减轻,但具有潜在的风险,如骨质去矿化和瘦肉质量损失.
- 缺乏导致骨质疏松症,胰岛素抵抗,贫血,疲劳,抑郁和性功能障碍.
结论:
- 将丸激素治疗与当代抗肥胖药物治疗相结合,提供了全面的好处.
- 这一综合战略旨在提高身体的性,并提高功能性阴道腺障碍的肥胖男性的生活质量.
相关概念视频
Glucagon-like Receptor Agonists
818
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
818
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Testosterone: Functions and Regulation
2.0K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
2.0K
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159

